Skip to content

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04988009
Enrollment
200
Registered
2021-08-03
Start date
2020-08-20
Completion date
2026-12-31
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Nervous System Neoplasm, Leptomeningeal Neoplasm, Metastatic Malignant Neoplasm in the Brain, Primary Brain Neoplasm

Brief summary

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate the patient-perceived quality of care by group (telemedicine versus in-person visits) in patients with central nervous system (CNS) cancer. SECONDARY OBJECTIVES: I. To characterize the visits provided by telemedicine compared to those in-person. II. To contrast the average time spent on telemedicine visits compared to in-person visits, and the delay between visit order placement and visit occurring. III. To evaluate the domains of patient care addressed on a telemedicine visit versus in-person visit per documentation, including (1) treatment planning, (2) symptom burden, (3) goals of care. IV. To evaluate frequency of acute care sought (through emergency room or urgent care clinic) within 30 days of encounter in telemedicine visit versus (vs) in-person visit. V. The impact of patient and clinical characteristics on perceived quality of care in the context of covariate-adjusted modeling. OUTLINE: Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.

Interventions

OTHERElectronic Health Record Review

Review of medical chart

OTHERSurvey Administration

Complete survey

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease * Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be * An in-person visit * A telemedicine appointment

Exclusion criteria

* Encounter occurred with the assistance of official language translation support * Patients with telephone encounters (without interactive video) * New patient or consult visits * Neither patient nor caregiver present during the visit are available or able to answer survey questions

Design outcomes

Primary

MeasureTime frameDescription
Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter")through study completion, an average of 1 yearSurvey responses will be summarized by ordinal category as counts with percentages, separately by group. Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval.

Secondary

MeasureTime frameDescription
Quality of Care Surveythrough study completion, an average of 1 yearWill separately estimate the proportion of each ordinal level of each group with 95% confidence interval.
Patients and clinical characteristicsBaselineDifferences between groups will be assessed by 2-sample 2-sided t-test and Mann-Whitney test, Fisher's exact test, or chi-square test.
Interactive time spent during visitthrough study completion, an average of 1 yearWill be summarized by group per mean, median, standard deviation, and range. Differences between groups will be assessed by t-test and Mann-Whitney test.
Time from visit order placement to visit occurringthrough study completion, an average of 1 yearWill be summarized by group per mean, median, standard deviation, and range. Differences between groups will be assessed by t-test and Mann-Whitney test.
Domains of patient care addressed during a visit, including treatment planning, symptom burden, and goals of carethrough study completion, an average of 1 yearWill be summarized as counts with percentages by group. Differences between groups will be assessed by chi-square test.
Incidence of acute care sought (through emergency room or urgent care clinic)Within 30 days of encounterWill be summarized as counts with percentages by group. Differences between groups will be provisionally assessed by Fisher's exact test.

Countries

United States

Contacts

CONTACTBarbara J O'Brien, MD
bjobrien@mdanderson.org713-794-4380
PRINCIPAL_INVESTIGATORBarbara J O'Brien, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026